Synthesis of carbocyclic and acyclic nucleosides possessing 2-fluoroadenine derivatives and their inhibitory activities against Plasmodium falciparum SAH hydrolase. 2003

Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
Department of Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido, Gifu 501-1193, Japan.

Carbocyclic and acyclic nucleosides possessing 2-fluoroadenine, such as 2-fluoronoraristeromycin (6) and 2-fluoro-9-[(2S,3R)-2,3,4-trihydroxy-butyl-1-yl]adenine (8), were synthesized and their inhibitory activities against human and Plasmodium falciparum recombinant SAH hydrolase were investigated.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006867 Hydrolases Any member of the class of enzymes that catalyze the cleavage of the substrate and the addition of water to the resulting molecules, e.g., ESTERASES, glycosidases (GLYCOSIDE HYDROLASES), lipases, NUCLEOTIDASES, peptidases (PEPTIDE HYDROLASES), and phosphatases (PHOSPHORIC MONOESTER HYDROLASES). EC 3. Hydrolase
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D043383 Adenosylhomocysteinase An enzyme which catalyzes the catabolism of S-ADENOSYLHOMOCYSTEINE to ADENOSINE and HOMOCYSTEINE. It may play a role in regulating the concentration of intracellular adenosylhomocysteine. S-adenosylhomocysteine Hydrolase,S-adenosylhomocysteine Synthase,SAH Hydrolase,Hydrolase, S-adenosylhomocysteine,S adenosylhomocysteine Hydrolase,S adenosylhomocysteine Synthase

Related Publications

Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
January 2000, Nucleic acids symposium series,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
August 2013, Parasitology international,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
August 2006, Bioorganic & medicinal chemistry,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
May 1969, Journal of medicinal chemistry,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
April 2008, Bioorganic & medicinal chemistry,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
March 2013, Interdisciplinary sciences, computational life sciences,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
January 1988, Chemistry of heterocyclic compounds,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
July 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Yukio Kitade, and Hiroharu Kojima, and Fazila Zulfiqur, and Saori Yabe, and Daisuke Yamagiwa, and Yasutomo Ito, and Masayuki Nakanishi, and Yoshihito Ueno, and Hye-Sook Kim, and Yusuke Wataya
March 2005, Chemical communications (Cambridge, England),
Copied contents to your clipboard!